Inventor · disambiguated record
Cendrine Lemoine
Also filed as: LEMOINE CENDRINE
12 granted patents·11 pending applications·32 citations·filing 2001–2025
86Inventor score
Top patents by PatentIndex Score
23 records- 0195US11530268B2Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2019·Granted Dec 20, 2022·15 cites·34 claims
- 0295US11365261B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2021·Granted Jun 21, 2022·3 cites·29 claims
- 0394US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 0494US11186649B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2018·Granted Nov 30, 2021·10 cites·41 claims
- 0582US12227573B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2023·Granted Feb 18, 2025·0 cites·45 claims
- 0676US10906978B2Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123SANOFI SA·Filed 2018·Granted Feb 2, 2021·1 cites·22 claims
- 0772US2023357401A1Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2022·Application pending·0 cites
- 0872US2022275102A1Anti-cd38 antibodies and methods of useSANOFI SA·Filed 2022·Application pending·0 cites
- 0971US2025250337A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 1070US12227560B2Anti-CHIKV antibodies and uses thereofSANOFI SA·Filed 2022·Granted Feb 18, 2025·0 cites·22 claims
- 1166US2023391888A1Pseudofab-based multispecific binding proteinsSANOFI SA·Filed 2023·Application pending·0 cites
- 1265US11505611B2FGFR3 antibodies and methods of useGENZYME CORP·Filed 2021·Granted Nov 22, 2022·0 cites·16 claims
- 1365US2023416395A1Anti-cd38 antibodies and formulationsSANOFI SA·Filed 2023·Application pending·0 cites
- 1465US2023303704A1Fgfr3 antibodies and methods of useGENZYME CORP·Filed 2022·Application pending·0 cites
- 1563US2021292423A1Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123SANOFI SA·Filed 2021·Application pending·0 cites
- 1661US11739160B2PseudoFab-based multispecific binding proteinsSANOFI SA·Filed 2019·Granted Aug 29, 2023·0 cites·36 claims
- 1758US11655302B2Anti-CD38 antibodies and formulationsSANOFI SA·Filed 2020·Granted May 23, 2023·0 cites·24 claims
- 1857US11286295B2Anti-CHIKV monoclonal antibodies directed against the E2 structural proteinSANOFI SA·Filed 2017·Granted Mar 29, 2022·0 cites·27 claims
- 1947US2021260165A1Combination therapy for treating hepatitis b virus infectionSANOFI SA·Filed 2019·Application pending·0 cites
- 2046US2018057597A1Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123SANOFI SA·Filed 2017·Application pending·0 cites
- 2146US2004185456A1Nucleic and proteinic acids corresponding to human gene ABC1AVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 2240US7378274B2Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic usesAVENTIS PHARMA SA·Filed 2001·Granted May 27, 2008·0 cites·11 claims
- 2333US2003087246A1Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cendrine Lemoine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →